Immuron (FRA:ANW) Days Inventory : 290.24 (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Immuron Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Immuron's Average Total Inventories for the six months ended in Dec. 2023 was €0.76 Mil. Immuron's Cost of Goods Sold for the six months ended in Dec. 2023 was €0.48 Mil. Hence, Immuron's Days Inventory for the six months ended in Dec. 2023 was 290.24.

The historical rank and industry rank for Immuron's Days Inventory or its related term are showing as below:

FRA:ANW' s Days Inventory Range Over the Past 10 Years
Min: 285.1 Med: 763.04 Max: 3904.07
Current: 322.26

During the past 9 years, Immuron's highest Days Inventory was 3904.07. The lowest was 285.10. And the median was 763.04.

FRA:ANW's Days Inventory is ranked worse than
71.08% of 650 companies
in the Biotechnology industry
Industry Median: 189.03 vs FRA:ANW: 322.26

Immuron's Days Inventory declined from Dec. 2022 (491.28) to Dec. 2023 (290.24).

Inventory Turnover measures how fast the company turns over its inventory within a year. Immuron's Inventory Turnover for the six months ended in Dec. 2023 was 0.63.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Immuron's Inventory-to-Revenue for the six months ended in Dec. 2023 was 0.52.

Immuron Days Inventory Historical Data

The historical data trend for Immuron's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuron Days Inventory Chart

Immuron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Inventory

Get a 7-Day Free Trial

291.11

355.08

3,732.95

456.82

438.12

Immuron Semi-Annual Data
	Jun15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial												558.11	235.33	491.28	363.26	290.24

Competitive Comparison of Immuron's Days Inventory

For the Biotechnology subindustry, Immuron's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immuron's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuron's Days Inventory distribution charts can be found below:

* The bar in red indicates where Immuron's Days Inventory falls into.

Immuron Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Immuron's Days Inventory for the fiscal year that ended in Jun. 2023 is calculated as

	Days Inventory (A: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Jun. 2022 )	+	Total Inventories (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (0.217	+	0.52)	/	2 )	/	0.307	*	365
=	0.3685					/	0.307	*	365
=	438.12

Immuron's Days Inventory for the quarter that ended in Dec. 2023 is calculated as:

	Days Inventory (Q: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Jun. 2023 )	+	Total Inventories (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0.52	+	0.994)	/	2 )	/	0.476	*	365 / 2
=	0.757					/	0.476	*	365 / 2
=	290.24

Immuron (FRA:ANW) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Immuron's Inventory Turnover for the six months ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0.476	/	0.757
	=	0.63

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Immuron's Inventory to Revenue for the six months ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0.757	/	1.446
	=	0.52

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Immuron Days Inventory Related Terms

Thank you for viewing the detailed overview of Immuron's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuron (FRA:ANW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuron Ltd (FRA:ANW) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

IMRN:USA ANWA:Germany IMC:Australia

Address

Chapman Street, Unit 10, 25-37, Blackburn North, Melbourne, VIC, AUS, 3130

Website

https://www.immuron.com.au

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

Immuron (FRA:ANW) Headlines

No Headlines